Corrigendum: Oxymatrine attenuates osteoclastogenesis via modulation of ROS-mediated SREBP2 signaling and counteracts ovariectomy-induced osteoporosis

Front Cell Dev Biol. 2022 Sep 9:10:1002132. doi: 10.3389/fcell.2022.1002132. eCollection 2022.

Authors

Chao Jiang^{1

2}, Qingliang Ma^{1

2}, Shiyu Wang^{1

2}, Yang Shen^{1

2}, An Qin³, Shunwu Fan^{1

2}, Zhiwei Jie^{1

2}

Affiliations

¹ Department of Orthopaedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou, China.
³ Department of Orthopaedics, Shanghai Key Laboratory of Orthopaedic Implant, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fcell.2021.684007.].

Keywords: ROS; SREBP2; osteoclast; osteoporosis; oxymatrine.

Copyright © 2022 Jiang, Ma, Wang, Shen, Qin, Fan and Jie.

Publication types

Published Erratum